- Senior Investigator, Epidemiology Branch / Molecular & Genetic Epidemiology Group
Dr. Taylor received a B.A. in biology at Carleton College, did graduate work in ecology and evolutionary biology at the University of Arizona, an M.D. at the University of Wisconsin Madison, and a Ph.D. in epidemiology at the University of North Carolina. He did his internship in radiology at Michigan State University, and his residency in preventive medicine at the University of North Carolina. He arrived at NIEHS in 1985 where he holds joint appointments in the Epidemiology Branch, and has his laboratory in the Laboratory of Molecular Carcinogenesis. He serves on the Board of Governors for the NIH Center for Inherited Disease Research as well as numerous other committees. He holds adjunct faculty appointments at the University of North Carolina and Duke University, and is a member of the Lineberger Comprehensive Cancer Center.
- (2019). Hormone therapy use and breast tissue DNA methylation: analysis of epigenome wide data from the normal breast study. Epigenetics. 14(2), 146-157.
- (2017). RELIC: a novel dye-bias correction method for Illumina Methylation BeadChip. BMC GENOMICS. 18,
- (2020). Reliability of DNA methylation measures using Illumina methylation BeadChip. Epigenetics.
- (2020). The Role of Blood Cell Composition in Epidemiologic Studies of Telomeres. EPIDEMIOLOGY. 31(4), E34-E36.
- (2020). Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. NATURE GENETICS. 52(6), 572-+.
- (2020). Prediagnostic Immune Cell Profiles and Breast Cancer. JAMA Network Open. 3(1),
- (2020). Blood DNA Methylation and Breast Cancer: A Prospective Case-Cohort Analysis in the Sister Study. JNCI-Journal of the National Cancer Institute. 112(1), 87-94.